bullish
Takeda FY17 Earnings - First Glance
113 Views15 May 2018 00:29
Takeda Pharmaceutical Co Ltd (4502 JP) reported FY17 results on May 14, 2018
As anticipated, Entyvio (YoY 35.9% to ¥196.6b), Takecab (YoY 61.7% to...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Takeda 1H FY18 (YE Mar'19) Results - First Glance31 Oct 2018
- Takeda FVE Reduction Leaves Shares Slightly Undervalued; Shire Acquisition Neutral to Valuation16 May 2018
- Takeda FY17 Earnings - First Glance15 May 2018
- Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal08 May 2018
- No Deal Is a Big Deal for Takeda25 Apr 2018
- Takeda Sweetens Offer for Shire: Deal – You Win! No-Deal – You Win Too!22 Apr 2018
x